Literature DB >> 30344337

Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation.

Monika Rana1, Hong-Jun Cho2, Tapta Kanchan Roy3, Liviu M Mirica2, Anuj K Sharma1.   

Abstract

Chemical tools are needed to discover new effective drugs for tackling multifaceted complex neurodegenerative diseases like Alzheimer's disease (AD). Multifunctional nature of two compounds, 5-((4-nitro-phenyl)diazenyl)quinolin-8-ol (HL1) and 4-((4-nitrophenyl)diazenyl)benzene-1,3-diol (HL2) is reported w.r.t. their ability to bind Cu2+ ions and amyloid aggregates related to AD. HL1 and HL2 have half congo-red type azo-stilbene structural framework incorporated with metal chelating groups, designed to chelate metal ions from metal-amyloid species. Metal binding studies of HL1 and HL2 are established by the methods of Job's Plot, UV-vis spectra with metal ions and stability constant determination. In addition, their metal complexes are isolated, purity checked by elemental analysis, spectroscopically characterized and their structural analyses were obtained from DFT based calculations including binding energy determination. Chicken egg white Lysozyme (CEWL) was used as a model peptide for fibrillation studies. HL1 is found as an excellent colorimetric sensor for amyloid fibrils. Inhibitory effect of HL1 and HL2 and their isolated metal complexes L1-Cu and L2-Cu on CEWL fibrillation was studied using ThT and ANS fluorescence assay along with TEM imaging. In addition, the cell toxicity studies on these compounds suggest that although azo dyes may be non-toxic but having a nitro-substitution lead to significant cell toxicity. Overall, these results suggest that this new class of multifunctional small molecules can interact with amyloids as well as metal ions and could be potential anti-aggregation metal chelating agents.

Entities:  

Year:  2017        PMID: 30344337      PMCID: PMC6191838          DOI: 10.1016/j.ica.2017.11.029

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  41 in total

Review 1.  Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions.

Authors:  T Lynch; R A Cherny; A I Bush
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

Review 2.  Bioinorganic chemistry of Alzheimer's disease.

Authors:  Kasper P Kepp
Journal:  Chem Rev       Date:  2012-07-13       Impact factor: 60.622

3.  Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation.

Authors:  Ying Zhang; Don L Rempel; Jun Zhang; Anuj K Sharma; Liviu M Mirica; Michael L Gross
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

4.  Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.

Authors:  Jung-Suk Choi; Joseph J Braymer; Ravi P R Nanga; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-03       Impact factor: 11.205

5.  Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.

Authors:  Alpaslan Dedeoglu; Kerry Cormier; Sandra Payton; Katya A Tseitlin; Jonathan N Kremsky; Li Lai; Xiaohua Li; Robert D Moir; Rudolph E Tanzi; Ashley I Bush; Neil W Kowall; Jack T Rogers; Xudong Huang
Journal:  Exp Gerontol       Date:  2004 Nov-Dec       Impact factor: 4.032

6.  Syntheses, X-ray structures, and physicochemical properties of phenoxo-bridged dinuclear nickel(II) complexes: kinetics of transesterification of 2-hydroxypropyl-p-nitrophenylphosphate.

Authors:  Sukanta Mandal; V Balamurugan; Francesc Lloret; Rabindranath Mukherjee
Journal:  Inorg Chem       Date:  2009-08-17       Impact factor: 5.165

7.  In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

Authors:  E M Castaño; J Ghiso; F Prelli; P D Gorevic; A Migheli; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

Review 8.  Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

Authors:  Peter Faller; Christelle Hureau
Journal:  Dalton Trans       Date:  2008-11-26       Impact factor: 4.390

9.  Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.

Authors:  Tim Storr; Michael Merkel; George X Song-Zhao; Lauren E Scott; David E Green; Meryn L Bowen; Katherine H Thompson; Brian O Patrick; Harvey J Schugar; Chris Orvig
Journal:  J Am Chem Soc       Date:  2007-05-19       Impact factor: 15.419

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  4 in total

1.  Rational Design of a Cu Chelator That Mitigates Cu-Induced ROS Production by Amyloid Beta.

Authors:  Suchitra Mitra; Kallol Talukdar; Pallavi Prasad; Sandeep K Misra; Shabana Khan; Joshua S Sharp; Jonah W Jurss; Saumen Chakraborty
Journal:  Chembiochem       Date:  2021-12-30       Impact factor: 3.461

2.  Selective separation of uranyl ions from some lanthanide elements using a promising β-enaminoester ligand by cloud point extraction.

Authors:  A B Abdallah; Adel M Youins; Mohamed R El-Kholany
Journal:  RSC Adv       Date:  2022-03-17       Impact factor: 3.361

3.  Aryldiazoquinoline based multifunctional small molecules for modulating Aβ42 aggregation and cholinesterase activity related to Alzheimer's disease.

Authors:  Monika Rana; Abhishek Pareek; Shivani Bhardwaj; Geeta Arya; Surendra Nimesh; Hemant Arya; Tarun K Bhatt; Srinivasarao Yaragorla; Anuj K Sharma
Journal:  RSC Adv       Date:  2020-08-04       Impact factor: 4.036

Review 4.  Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.

Authors:  Hafza Wajeeha Ejaz; Wei Wang; Minglin Lang
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.